The leading foreign investor in the Chinese company embroiled in a legal spat with Morgan Stanley over derivatives is Goldman Sachs, the US investment bank's arch rival.
Morgan Stanley and China Haisheng Juice Holdings are battling in English and Chinese courts over a disputed hedging contract.
The case is the most public example to date of the stand-off between foreign investment banks and mainland companies over derivatives deals, which has resulted in a collapse in such structured product deals in China this year.
您已閱讀19%（520字），剩餘81%（2196字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。